In World First, Polish Pharmaceutical Company Produces Plasma-Derived COVID Drug
Polish pharmaceutical company Biomed Lublin has started producing a coronavirus drug from human plasma with COVID-19 antibodies.
Polish pharmaceutical company Biomed Lublin has started producing a coronavirus drug from human plasma with COVID-19 antibodies.
The World Health Organization declared Thursday that the new coronavirus epidemic was at a "decisive point" as countries across the ...
Do you like our reporting?
SUBSCRIBE
© 2018 The Globe Post
© 2018 The Globe Post